SY1 Symrise AG

EQS-News: Symrise continues strong profitable growth course

EQS-News: Symrise AG / Key word(s): 9 Month figures
Symrise continues strong profitable growth course (news with additional features)

24.10.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Trading Statement 9M 2024
Holzminden, 24 October 2024
Symrise continues strong profitable growth course  
  • Group sales up 11.1% (organic) to €3,824 million in the first nine months, up 10.2% in the third quarter
  • Both segments, Taste, Nutrition & Health and Scent & Care, achieved double digit growth
  • Organic sales target expected to be around 7% for the full year 2024 

Symrise continued its profitable growth trajectory in the first nine months of the year, achieving organic sales growth of 11.1%. Considering portfolio and exchange rate effects, Group revenue rose to €3,824 million in the first nine months (9M 2023: €3,610 million), a plus of 5.9% compared to the year-ago period. Both segments contributed to the positive development and increased sales in a global economic environment that remained challenging. In the third quarter, overall sales increased organically by 10.2%. Despite negative exchange rate effects of 4.0%, sales grew by 5.2% in the reporting currency. Against the backdrop of robust organic growth, Symrise has specified its organic growth target, sales expected to come in at around 7 %.

Jean-Yves Parisot, CEO of Symrise AG: " Symrise was able to seamlessly continue the positive business development of the past months in the third quarter. Despite the current volatile market environment due to geopolitical tensions and continued inflation pressure, we are confident for the rest of the year and expect robust demand. Our diversified portfolio and broad, international footprint will continue to help us realize our growth potential and create sustainable value this year. We are firmly convinced that we have set the right course for the future."

Sales development by region
The strongest organic growth was recorded in the Latin America region with 27.4%, followed by the Asia/Pacific region with 11.2% and EAME (Europe, Africa, Middle East) with 11.1%. The main growth drivers were the Food & Beverage, Fragrance, Aroma Molecules and Pet Food business units. The North America region achieved organic growth of 2.3%, driven primarily by the Food & Beverage and Aroma Molecules business units.

High growth in food, beverages and pet food
The Taste, Nutrition & Health segment increased sales organically by 10.4% in the first nine months of the current fiscal year. In the third quarter, organic growth was 11.3%. Taking into account portfolio and currency effects, the segment's revenue rose to €2,349 million in the first nine months (9M 2023: €2,267 million). The portfolio effect from the sale of the beverage trading business in the UK within the Food & Beverage business unit had a negative impact of € 27 million on sales development.

The Food & Beverage division achieved double-digit organic growth in percentage terms. Strong growth impulses came from the application areas for sweet and savory products and beverages. All four regions, especially the EAME region, achieved high growth. The Naturals application area increased its revenues, especially in the North America and EAME regions.

The Pet Food division also achieved double-digit organic growth in percentage terms in the first nine months. Sales development was particularly dynamic in the Asia/Pacific and Latin America regions, with double-digit organic growth.
Sales development in the Aqua Feed business unit recorded declining organic growth. As part of the further portfolio streamlining with a focus on high-margin growth areas, Symrise intends to sell the business.
The probiotics business, which includes the majority stake in the listed company Probi AB, Lund, Sweden, generated slight growth, driven by the EAME region.

Strong sales growth in Consumer Fragrance and significant recovery in Aroma Molecules
The Scent & Care segment, which manages the fragrances, perfumery applications and cosmetic active ingredients business, achieved organic sales growth of 12.2% in the first nine months and 8.4% in the third quarter respectively. Taking into account portfolio and currency effects, revenue for the first nine months amounted to €1,475 million (9M 2023: €1,343 million).

The Fragrance division increased its sales organically in the double-digit percentage range in the first nine months. In particular, the Consumer Fragrance application area achieved double-digit percentage growth. The EAME, Asia/Pacific and Latin America regions in particular experienced very high market dynamics. The Fine Perfumery application area also continued its very positive development and achieved high single-digit percentage organic growth. Here, the Latin America and Asia/Pacific regions recorded good growth. The Oral Care application area achieved single-digit percentage organic growth, with good growth especially in the North America and Asia/Pacific regions.

Sales in the Aroma Molecules division recovered significantly in the first nine months of the current year. While the market environment continues to prove challenging, the resumption of production in Colonels Island, USA has resulted in a significant year-on-year increase in revenue. High double-digit growth figures were achieved in all regions.

Sales in the Cosmetic Ingredients division continued to develop strongly with high single-digit percentage organic growth. Revenues increased significantly in the EAME, Asia/Pacific and Latin America regions. Only the North America region showed just a slight year-on-year growth. The application areas for micro-protection and actives and botanicals also recorded very strong growth impulses.

Symrise specifies growth target for 2024
Based on the good business performance in the first nine months, Symrise is specifying its sales target for the full year 2024. The Group is now aiming for organic sales growth of around 7%. The Group's long-term organic growth expectation of 5% to 7% (CAGR) remains unchanged. The long-term EBITDA margin is expected to be in the range of 20% to 23%.


About Symrise: Symrise is a global supplier of fragrances and flavors, cosmetic basic and active ingredients as well as functional ingredients. Its customers include perfume, cosmetics, food and beverage manufacturers, the pharmaceutical industry and producers of dietary supplements and pet food. With sales of around €4.7 billion in the 2023 financial year, the company is one of the world's leading providers. The Group, headquartered in Holzminden, Germany, has more than 100 branches in Europe, Africa and the Middle East, Asia, the USA and Latin America. Together with its customers, Symrise develops new ideas and marketable concepts for products that have become an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...

 
Contact media:  
Bernhard Kott  
Phone: +49 (0)5531 90-1721  
E-mail:  
   
Social media:  

 

Additional features:

File:


24.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail:
Internet:
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2014813

 
End of News EQS News Service

2014813  24.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2014813&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
24/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Symrise AG

Michael B. Schäfer
  • Michael B. Schäfer

Symrise : CMD feedback - Evolutionary strategy update, slightly raised...

>Evolutionary strategy update, no dedicated efficiency programme beyond 2024 - Symrise hosted a CMD 7 months after Jean-Yves Parisot took over as CEO, providing a rather evolutionary strategy update compared to the CMD in October 2023 where 'growth' remains the key driver of the new 'One Symrise Strategy'. However, leveraging its global scale by implementing best practices across segments and active portfolio management (both ways) doubled its weight (40% vs 20%) in t...

 PRESS RELEASE

EQS-News: Symrise Capital Market Day: Unleashing the full beauty of O...

EQS-News: Symrise AG / Key word(s): Capital Markets Day Symrise Capital Market Day: Unleashing the full beauty of ONE Symrise, being and staying unique 20.11.2024 / 15:30 CET/CEST The issuer is solely responsible for the content of this announcement. Press release — Holzminden, 20 November 2024 ONE Symrise strategy to sustain continuous growth and increased focus on profitability Outlook upgraded for 2024: organic growth is now expected above 7% and EBITDA margin above 20% Long-term targets for 2028: organic sales growth at 5-7% CAGR (unchanged), EBITDA margin rang...

 PRESS RELEASE

EQS-News: Kapitalmarkttag von Symrise: Unleashing the full beauty of O...

EQS-News: Symrise AG / Schlagwort(e): Kapitalmarkttag Kapitalmarkttag von Symrise: Unleashing the full beauty of ONE Symrise, das Motto des Strategie-Updates 20.11.2024 / 15:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung — Holzminden, 20. November 2024 ONE Symrise Strategie zur Sicherung des kontinuierlichen Wachstums mit verstärktem Fokus auf Profitabilität Ausblick für 2024 angehoben: Organisches Wachstum über 7 % und EBITDA-Marge über 20 % Langfristziele für 2028: Organisches Umsatzwachstum von 5-7 % CA...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch